About Careers Internship MedBlog Contact us

'Liver-Stage Malaria in a Dish' Enables to Study the Influence of Host Genetics on Antimalarial Drug Efficacy

by Dr. Trupti Shirole on February 6, 2015 at 9:07 PM
 'Liver-Stage Malaria in a Dish' Enables to Study the Influence of Host Genetics on Antimalarial Drug Efficacy

A Massachusetts Institute of Technology (MIT) research team has engineered a way to use human liver cells, derived from induced pluripotent stem cells (iPSCs), to screen potential antimalarial drugs and vaccines for their ability to treat the liver stage of malaria infection. This novel approach may offer new opportunities for personalized antimalarial drug testing and the development of more effective individually tailored drugs to combat the disease, which leads to more than 500,000 deaths worldwide each year.

Author Sangeeta Bhatia said, "Our platform can be used for testing candidate drugs that act against the parasite in the early liver stages, before it causes disease in the blood and spreads back to the mosquito vector and this is especially important given the increasing occurrence of drug-resistant strains of malaria in the field."


However, current methods for modeling liver-stage malaria in a dish are limited due to the small available pool of liver cells from human donors and the lack of genetic diversity of these donor cells. To overcome these hurdles, Bhatia and her research team reprogrammed human skin cells into iPSCs, embryonic-like stem cells capable of turning into other specific cell types relevant for studying a particular disease.

The researchers infected iPSC-derived liver cells with various malaria parasites to model liver-stage malaria in the laboratory. They found that these cells were sensitive to an antimalarial drug called atovaquone. Chemical maturation through exposure to small molecules also made the cells sensitive to another antimalarial drug called primaquine. Thus, they demonstrated the value of this approach for testing new antimalarial drugs.

Lead author Shengyong Ng said, "The use of iPSC-derived liver cells to model liver-stage malaria in a dish opens the door to study the influence of host genetics on antimalarial drug efficacy and lays the foundation for their use in antimalarial drug discovery."

The study is published in the journal of the International Society for Stem Cell Research.

Source: Medindia
Font : A-A+



Recommended Readings

Latest Tropical Disease News

Rare Zika Case Emerges in Cambodia After Seven Years
The Ministry of Health (MoH) in Cambodia has reported the first Zika virus case in the country since 2016.
Global Spread of Mpox Virus Persists: Cases Reported in China and Thailand
The WHO has assessed the risk of monkeypox for the general population in countries not previously impacted by the current outbreak as low.
Understanding Nipah Virus: Droplet Transmission and Its Lethality at 40-70%
Nipah is a zoonotic virus, meaning it can be transmitted from animals to humans. Fruit bats serve as the natural reservoirs for Nipah virus.
Tamil Nadu Reports Zero Nipah Virus Cases
Nipah Virus (NiV) or Hendra virus is a deadly virus that spreads via contact with the saliva, urine, or excreta of fruit bats or pigs.
Nipah Virus Outbreak: 2 Fatalities Trigger Emergency Response in Kozhikode
Nipah virus is mainly a zoonotic disease, transferring from animals to humans, and can also spread via contaminated food or contact with infected individuals.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

'Liver-Stage Malaria in a Dish' Enables to Study the Influence of Host Genetics on Antimalarial Drug Efficacy Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests